Ernexa Therapeutics Inc. (ERNA) Gross Profit (2010 - 2024)
Ernexa Therapeutics' (ERNA) quarterly Gross Profit came in at $1000.0 in Q4 2024, up 102.04% YoY from $494.95 in Q1 2024, and down 99.82% on a QoQ basis from $547000.0 in Q3 2024.
Ernexa Therapeutics Inc. (ERNA) Gross Profit (2010 - 2024) Analysis & Trends
Ernexa Therapeutics (ERNA) has 13 years of Gross Profit data on file, last reported at $1000.0 in Q4 2024.
- Quarterly Gross Profit rose 102.04% year-over-year to $1000.0 in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $486000.0 (up 389.29% YoY) and the FY2024 annual result came in at $486000.0, up 389.29% from the prior year.
- Gross Profit slipped to $1000.0 in Q4 2024, from $547000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $1.4 million in Q1 2020 to a low of -$69000.0 in Q3 2023.
- A 3-year average of $300000.0 and a median of -$6500.0 in 2024 frame the typical range for Gross Profit.
- Annual changes were most pronounced in 2020 — Gross Profit plunged 79.11% — and 2024, when it jumped 892.75%.
- Tracing ERNA's Gross Profit over 3 years: stood at $562000.0 in 2020, then slumped by 108.72% to -$49000.0 in 2023, then jumped by 102.04% to $1000.0 in 2024.
- The last three Gross Profit figures came in at $1000.0 (Q4 2024), $547000.0 (Q3 2024), and -$48000.0 (Q2 2024), per Business Quant data.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Sep 30, 2024 | 547,000.00 |
| Sep 30, 2024 | 547,000.00 |
| Jun 30, 2024 | -48,000.00 |
| Jun 30, 2024 | -48,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Mar 31, 2024 | -14,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Dec 31, 2023 | -49,000.00 |
| Sep 30, 2023 | -69,000.00 |
| Sep 30, 2023 | -69,000.00 |
| Mar 31, 2023 | -50,000.00 |
| Mar 31, 2023 | -50,000.00 |
| Dec 31, 2020 | 562,000.00 |
| Dec 31, 2020 | 562,000.00 |
| Sep 30, 2020 | 676,000.00 |
| Sep 30, 2020 | 676,000.00 |
| Mar 31, 2020 | 1.44 Mn |
| Mar 31, 2020 | 1.44 Mn |